A respiratory device that Baxter inherited through its $12.5 billion Hillrom acquisition might work a little too well, a problem that prompted the company to issue an urgent medical device correction.
A device that’s meant to clear out and expand the lungs may actually go too far, resulting in a potentially dangerous decrease in overall oxygen levels, Baxter said this week. In light of that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results